High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria
High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria is a paper indexed in ScholarIQ from OpenAlex.
How many citations does High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria have?
High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria has 89 citations in the OpenAlex counts ScholarIQ stores.
When was High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria published?
High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria has 2019 year in the ScholarIQ index.
What is the open-access status of High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria?
High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria has closed oa status in the ScholarIQ index.
What is the DOI of High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria?
The DOI for High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria is on the source record.
What is the PMID of High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria?
The PMID for High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria is on the source record.
What is the OpenAlex record for High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria?
The OpenAlex for High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria is on the source record.